Asia-Pacific Baby Infant Formula Market Overview:
The Asia-Pacific baby infant formula market size was valued at USD 11.4 billion in 2017, and is estimated to reach USD 26.8 billion by 2026 with a CAGR of 9.8% from 2019 to 2026.
Nutrition is one of the most significant factors that influences a child’s development and growth. The baby infant formula market comprises a diversified range of products from various infant formulas to baby food products. According to the Federal Food, Drug, and Cosmetic Act, infant formula refers to the food for dietary use that is solely fed to infants, owing to the fact that it simulates the nutritious properties of human milk or serves as a complete or partial substitute of human milk.
The growth of the Asia-Pacific baby infant formula market is majorly driven by increase in awareness offered by baby infant formula such as it facilitates healthy growth & development of babies, improves cognitive performance & development, prevents them from allergies, and enhances gastrointestinal health & immunity.
Moreover, the rise in the middle-class population in emerging economies significantly contributes toward the growth of the market, owing to their high purchasing power and affordability to spend on children. In addition, rapid urbanization has led to the changes in the lifestyle of people. For instance, China and India with large population bases have witnessed economic boom in the past decades, offering remunerative business opportunities for market expansion. Thus, the rise in disposable income in countries such as China, India, Brazil, Indonesia, and others is anticipated to boost the growth of Asia-Pacific baby infant formula market.
Furthermore, breastfeeding is not always possible for working mothers; thus, baby infant formula serves as an appropriate alternative for infants, as its composition is similar to that of breastmilk. Baby infant formulas contain nucleotides necessary for the metabolic processes, such as energy metabolism and enzymatic reactions. These nucleotides act as building blocks of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) for normal body functions. Furthermore, iron-rich infant formula helps to prevent anemia. Various infant formulas are based on probiotics, which help to prevent diarrhea, ease colic, and reduce the risk of food allergies. Moreover, infant formulas are rich in protein, linoleic acid, minerals, calcium, carbohydrates, phosphorus, iodine, sodium chloride, potassium chloride, and other nutrients, which are necessary for proper development of infants. Thus, physicians recommend the use of infant formula for babies as a substitute to breast milk, owing to its high nutritional content, thereby boosting the Asia-Pacific baby infant formula market demand.
Baby infant formula consists of infant milk, follow-on-milk, specialty baby milk, and growing-up milk formulated for the consumption of infants and toddlers. Infant milk contains the necessary nutrients, minerals, and vitamins for a baby to thrive and grow. Upsurge in participation of women in the labor force has further led to rise in the number of women professionals who prefer infant formula for their babies. This is expected to considerably augment the Asia-Pacific baby infant formula market growth.
The Asia-Pacific baby infant formula market is segmented into type, ingredient, distribution channel, and country. By type, the market is categorized into infant milk, follow-on-milk, specialty baby milk, and growing-up milk. Depending on the ingredient, it is classified into carbohydrate, fat, protein, minerals, vitamins and others. As per distribution channel, it is segregated into hypermarket, supermarket, pharmacy/medical stores, specialty stores, hard discounter stores, e-commerce, and others. Country wise, the market is analyzed across China, India, South Korea, Japan, Philippines, Indonesia, Australia, New Zealand, and rest of Asia-Pacific.
On the basis of type, the infant milk segment led in terms of Asia-Pacific baby infant formula market share in 2017, and is expected to retain its dominance during the forecast period. This is attributed to an increase in the number of working women, who majorly prefer infant milk for their babies, since breastfeeding is not always a feasible option for them. Moreover, many working women resume at work shortly after giving birth, which makes them opt for alternatives, such as infant milk, to feed their child.
Depending on the ingredient, the carbohydrate segment dominated the market in 2017, due to the fact that carbohydrates are an infant's essential source for proper growth and development. Intake of nutrient-dense carbohydrates by infants is expected to optimize their growth and maintain a healthy body weight, which further fuels the growth of the segment.
By distribution channel, the supermarket segment garnered the highest share of the Asia-Pacific baby infant formula market in 2017. This is attributed to the fact that supermarkets are gaining popularity, owing to the availability of a broad range of consumer goods under a single roof, ample parking space, and convenient operation timings. Moreover, increase in urbanization, rise in working class population, and competitive pricing boost the popularity of supermarkets in developed and developing countries.
The key players operating in the Asia-Pacific baby infant formula market industry include Abbott, Arla Foods Amba, Campbell Soups, Dana Dairy Group Ltd., Danone, Nestle S.A., Reckitt Benckiser (Mead Johnson & Company LLC), Perrigo Company Plc, Heinz Baby, and Gujarat Co-operative Milk Marketing Federation Ltd. (GCMMF).
Key Benefits for Stakeholders:
Key Market Segments:
By Type
By Ingredient
By Distribution Channel
By Country
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings
2.1.1. Top impacting factors
2.1.2. Top investment pockets
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Market evolution/industry roadmap
3.3. Key forces shaping Asia-Pacific baby infant formula industry/market
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Innovative packaging to influence buying behavior
3.5.1.2. Rise in disposable income
3.5.1.3. Increase in awareness toward adequate nutrition
3.5.1.4. Busy consumer lifestyle
3.5.2. Restraint
3.5.2.1. Increase in breastfeeding due to government initiatives
3.5.3. Opportunities
3.5.3.1. Surge in preference for organic infant formula food
3.5.3.2. Increase in use of goat milk in baby infant formula
3.5.3.3. Addition of prebiotic and probiotics in infant food
CHAPTER 4: ASIA-PACIFIC BABY INFANT FORMULA MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast, by Asia-Pacific
4.2. Infant milk
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by country
4.2.3. Market analysis, by country
4.3. Follow-on milk
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by country
4.3.3. Market analysis, by country
4.3.4. Specialty baby milk
4.3.5. Key market trends, growth factors, and opportunities
4.3.6. Market size and forecast, by country
4.3.7. Market analysis, by country
4.4. Growing-up milk
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by country
4.4.3. Market analysis, by country
CHAPTER 5: ASIA-PACIFIC BABY INFANT FORMULA MARKET, BY INGRDIENT
5.1. Overview
5.1.1. Market size and forecast, by ingredient
5.2. Carbohydrate
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by country
5.2.3. Market analysis, by country
5.3. Fat
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by country
5.3.3. Market analysis, by country
5.4. Protein
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by country
5.4.3. Market analysis, by country
5.5. Minerals
5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast, by country
5.5.3. Market analysis, by country
5.6. Vitamins
5.6.1. Key market trends, growth factors, and opportunities
5.6.2. Market size and forecast, by country
5.6.3. Market analysis, by country
5.7. Others
5.7.1. Key market trends, growth factors, and opportunities
5.7.2. Market size and forecast, by country
5.7.3. Market analysis, by country
CHAPTER 6: ASIA-PACIFIC BABY INFANT FORMULA MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast, by distribution channel
6.2. Hypermarket
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.3. Market analysis by country
6.3. Supermarket
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.3. Market analysis by country
6.4. Pharmacy/medical store
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.3. Market analysis by country
6.5. Specialty stores
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.3. Market analysis by country
6.6. Hard discounter store
6.6.1. Key market trends, growth factors, and opportunities
6.6.2. Market size and forecast, by country
6.6.3. Market analysis by country
6.7. E-commerce
6.7.1. Key market trends, growth factors, and opportunities
6.7.2. Market size and forecast, by country
6.7.3. Market analysis by country
6.8. Others
6.8.1. Key market trends, growth factors, and opportunities
6.8.2. Market size and forecast, by country
6.8.3. Market analysis by country
CHAPTER 7: ASIA-PACIFIC BABY INFANT FORMULA MARKET, BY COUNTRY
7.1. Overview
7.1.1. Asia-Pacific
7.1.2. Key market trends, growth factors, and opportunities
7.1.3. Market analysis by country
7.1.3.1. China
7.1.3.1.1. Market size and forecast, by type
7.1.3.1.2. Market size and forecast, by ingredient
7.1.3.1.3. Market size and forecast, by distribution channel
7.1.3.2. India
7.1.3.2.1. Market size and forecast, by type
7.1.3.2.2. Market size and forecast, by ingredient
7.1.3.2.3. Market size and forecast, by distribution channel
7.1.3.3. South Korea
7.1.3.3.1. Market size and forecast, by type
7.1.3.3.2. Market size and forecast, by ingredient
7.1.3.3.3. Market size and forecast, by distribution channel
7.1.3.4. Japan
7.1.3.4.1. Market size and forecast, by type
7.1.3.4.2. Market size and forecast, by ingredient
7.1.3.4.3. Market size and forecast, by distribution channel
7.1.3.5. Philippines
7.1.3.5.1. Market size and forecast, by type
7.1.3.5.2. Market size and forecast, by ingredient
7.1.3.5.3. Market size and forecast, by distribution channel
7.1.3.6. Indonesia
7.1.3.6.1. Market size and forecast, by type
7.1.3.6.2. Market size and forecast, by ingredient
7.1.3.6.3. Market size and forecast, by distribution channel
7.1.3.7. Australia
7.1.3.7.1. Market size and forecast, by type
7.1.3.7.2. Market size and forecast, by ingredient
7.1.3.7.3. Market size and forecast, by distribution channel
7.1.3.8. New Zealand
7.1.3.8.1. Market size and forecast, by type
7.1.3.8.2. Market size and forecast, by ingredient
7.1.3.8.3. Market size and forecast, by distribution channel
7.1.3.9. Rest of Asia-Pacific
7.1.3.9.1. Market size and forecast, by type
7.1.3.9.2. Market size and forecast, by ingredient
7.1.3.9.3. Market size and forecast, by distribution channel
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Product mapping
8.2. Competitive dashboard
8.3. Competitive heatmap
CHAPTER 9: COMPANY PROFILES
9.1. ABBOTT LABORATORIES (ABBOTT)
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. R&D Expenditure
9.1.7. Business performance
9.1.8. Key strategic moves and developments
9.2. ARLA FOODS AMBA (ARLA)
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. R&D Expenditure
9.2.7. Business performance
9.3. CAMPBELL SOUP COMPANY
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. R&D Expenditure
9.3.7. Business performance
9.4. DANA DAIRY GROUP LTD.
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Product portfolio
9.4.5. Key strategic moves and developments
9.5. DANONE
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. R&D Expenditure
9.5.7. Business performance
9.6. GUJARAT CO-OPERATIVE MILK MARKETING FEDERATION LTD. (GCMMF)
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Product portfolio
9.6.5. Business performance
9.7. NESTLE S.A.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. R&D Expenditure
9.7.7. Business performance
9.8. PERRIGO COMPANY PLC
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. R&D Expenditure
9.8.7. Business performance
9.9. RECKITT BENCKISER GROUP PLC.
9.9.1. Company overview
9.9.2. Key executive
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. R&D expenditure
9.9.7. Business performance
9.10. THE KRAFT HEINZ COMPANY
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Product portfolio
9.10.5. R&D Expenditure
9.10.6. Business performance
LIST OF TABLES
TABLE 01. ASIA-PACIFIC BABY INFANT FORMULA MARKET, BY TYPE, 2017–2026 ($MILLION)
TABLE 02. ASIA-PACIFIC BABY INFANT FORMULA MARKET VOLUME, BY TYPE, 2017–2026 (KILOTON)
TABLE 03. ASIA-PACIFIC BABY INFANT FORMULA MARKET REVENU FOR INFANT MILK , BY COUNTRY, 2017–2026 ($MILLION)
TABLE 04. ASIA-PACIFIC BABY INFANT FORMULA MARKET VOLUME FOR INFANT MILK, BY COUNTRY, 2017–2026 (KILOTON)
TABLE 05. ASIA-PACIFIC BABY INFANT FORMULA MARKET REVENUE FOR FOLLOW-ON MILK, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 06. ASIA-PACIFIC BABY INFANT FORMULA MARKET VOLUME FOR FOLLOW-ON MILK, BY COUNTRY, 2017–2026 (KILOTON)
TABLE 07. ASIA-PACIFIC BABY INFANT FORMULA MARKET REVENUE FOR SPECIALTY BABY MILK, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 08. ASIA-PACIFIC BABY INFANT FORMULA MARKET VOLUME FOR SPECIALTY BABY MILK, BY COUNTRY, 2017–2026 (KILOTON)
TABLE 09. ASIA-PACIFIC BABY INFANT FORMULA MARKET REVENUE FOR GROWING-UP MILK, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 10. ASIA-PACIFIC BABY INFANT FORMULA MARKET VOLUME FOR GROWING-UP MILK, BY COUNTRY, 2017–2026 (KILOTON)
TABLE 11. ASIA-PACIFIC BABY INFANT FORMULA MARKET REVENUE, BY INGREDIENT, 2017–2026 ($MILLION)
TABLE 12. ASIA-PACIFIC BABY INFANT FORMULA MARKET BY REVENUE FOR CARBOHYDRATE, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 13. ASIA-PACIFIC BABY INFANT FORMULA MARKET BY REVENUE FOR FAT, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 14. ASIA-PACIFIC BABY INFANT FORMULA MARKET BY REVENUE FOR PROTEIN, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 15. ASIA-PACIFIC BABY INFANT FORMULA MARKET BY REVENUE FOR MINERALS, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 16. ASIA-PACIFIC BABY INFANT FORMULA MARKET BY REVENUE FOR VITAMINS, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 17. ASIA-PACIFIC BABY INFANT FORMULA MARKET BY REVENUE FOR OTHERS, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 18. ASIA-PACIFIC BABY INFANT FORMULA MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2026 ($MILLION)
TABLE 19. ASIA-PACIFIC BABY INFANT FORMULA MARKET BY REVENUE FOR HYPERMARKET, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 20. ASIA-PACIFIC BABY INFANT FORMULA MARKET BY REVENUE FOR SUPERMARKET, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 21. ASIA-PACIFIC BABY INFANT FORMULA MARKET BY REVENUE FOR PHARMACY/MEDICAL STORE, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 22. ASIA-PACIFIC BABY INFANT FORMULA MARKET BY REVENUE FOR SPECIALTY STORES, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 23. ASIA-PACIFIC BABY INFANT FORMULA MARKET BY REVENUE FOR HARD DISCOUNTER STORE, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 24. ASIA-PACIFIC BABY INFANT FORMULA MARKET BY REVENUE FOR E-COMMERCE, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 25. ASIA-PACIFIC BABY INFANT FORMULA MARKET BY REVENUE FOR OTHERS, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 26. ASIA-PACIFIC BABY INFANT FORMULA MARKET REVENUE, BY COUNTRY, 2017–2026 ($MILLION)
TABLE 27. ASIA-PACIFIC BABY INFANT FORMULA MARKET VOLUME, BY COUNTRY, 2017–2026 (KILOTON)
TABLE 28. CHINA BABY INFANT FORMULA MARKET REVENUE, BY TYPE, 2017–2026 ($MILLION)
TABLE 29. CHINA BABY INFANT FORMULA MARKET VOLUME, BY TYPE, 2017–2026 (KILOTON)
TABLE 30. CHINA BABY INFANT FORMULA MARKET REVENUE, BY INGREDIENT, 2017–2026 ($MILLION)
TABLE 31. CHINA BABY INFANT FORMULA MARKET REVENUE, BY DISTRIBUTION CHANNEL, 20172017–2026 ($MILLION)
TABLE 32. INDIA BABY INFANT FORMULA MARKET REVENUE, BY TYPE, 2017–2026 ($MILLION)
TABLE 33. INDIA BABY INFANT FORMULA MARKET VOLUME, BY TYPE, 2017–2026 (KILOTON)
TABLE 34. INDIA BABY INFANT FORMULA MARKET REVENUE, BY INGREDIENT, 2017–2026 ($MILLION)
TABLE 35. INDIA BABY INFANT FORMULA MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2026 ($MILLION)
TABLE 36. SOUTH KOREA BABY INFANT FORMULA MARKET REVENUE, BY TYPE, 2017–2026 ($MILLION)
TABLE 37. SOUTH KOREA BABY INFANT FORMULA MARKET VOLUME, BY TYPE, 2017–2026 (KILOTON)
TABLE 38. SOUTH KOREA BABY INFANT FORMULA MARKET REVENUE, BY INGREDIENT, 2017–2026 ($MILLION)
TABLE 39. SOUTH KOREA BABY INFANT FORMULA MARKET REVENUE, BY DISTRIBUTION CHANNEL, 20172017–2026 ($MILLION)
TABLE 40. JAPAN BABY INFANT FORMULA MARKET REVENUE, BY TYPE, 2017–2026 ($MILLION)
TABLE 41. JAPAN BABY INFANT FORMULA MARKET VOLUME, BY TYPE, 2017–2026 (KILOTON)
TABLE 42. JAPAN BABY INFANT FORMULA MARKET REVENUE, BY INGREDIENT, 2017–2026 ($MILLION)
TABLE 43. JAPAN BABY INFANT FORMULA MARKET REVENUE, BY DISTRIBUTION CHANNEL, 20172017–2026 ($MILLION)
TABLE 44. PHILIPPINES BABY INFANT FORMULA MARKET REVENUE, BY TYPE, 2017–2026 ($MILLION)
TABLE 45. PHILIPPINES BABY INFANT FORMULA MARKET VOLUME, BY TYPE, 2017–2026 (KILOTON)
TABLE 46. PHILIPPINES BABY INFANT FORMULA MARKET REVENUE, BY INGREDIENT, 2017–2026 ($MILLION)
TABLE 47. PHILIPPINES BABY INFANT FORMULA MARKET REVENUE, BY DISTRIBUTION CHANNEL, 20172017–2026 ($MILLION)
TABLE 48. INDONESIA BABY INFANT FORMULA MARKET REVENUE, BY TYPE, 2017–2026 ($MILLION)
TABLE 49. INDONESIA BABY INFANT FORMULA MARKET VOLUME, BY TYPE, 2017–2026 (KILOTON)
TABLE 50. INDONESIA BABY INFANT FORMULA MARKET REVENUE, BY INGREDIENT, 2017–2026 ($MILLION)
TABLE 51. INDONESIA BABY INFANT FORMULA MARKET REVENUE, BY DISTRIBUTION CHANNEL, 20172017–2026 ($MILLION)
TABLE 52. AUSTRALIA BABY INFANT FORMULA MARKET REVENUE, BY TYPE, 2017–2026 ($MILLION)
TABLE 53. AUSTRALIA BABY INFANT FORMULA MARKET VOLUME, BY TYPE, 2017–2026 (KILOTON)
TABLE 54. AUSTRALIA BABY INFANT FORMULA MARKET REVENUE, BY INGREDIENT, 2017–2026 ($MILLION)
TABLE 55. AUSTRALIA BABY INFANT FORMULA MARKET REVENUE, BY DISTRIBUTION CHANNEL, 20172017–2026 ($MILLION)
TABLE 56. NEW ZEALAND BABY INFANT FORMULA MARKET REVENUE, BY TYPE, 2017–2026 ($MILLION)
TABLE 57. NEW ZEALAND BABY INFANT FORMULA MARKET VOLUME, BY TYPE, 2017–2026 (KILOTON)
TABLE 58. NEW ZEALAND BABY INFANT FORMULA MARKET REVENUE, BY INGREDIENT, 2017–2026 ($MILLION)
TABLE 59. NEW ZEALAND BABY INFANT FORMULA MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2026 ($MILLION)
TABLE 60. REST OF ASIA-PACIFIC BABY INFANT FORMULA MARKET REVENUE, BY TYPE, 2017–2026 ($MILLION)
TABLE 61. REST OF ASIA-PACIFIC BABY INFANT FORMULA MARKET VOLUME, BY TYPE, 2017–2026 (KILOTON)
TABLE 62. REST OF ASIA-PACIFIC BABY INFANT FORMULA MARKET REVENUE, BY INGREDIENT, 2017–2026 ($MILLION)
TABLE 63. REST OF ASIA-PACIFIC BABY INFANT FORMULA MARKET REVENUE, BY DISTRIBUTION CHANNEL, 20172017–2026 ($MILLION)
TABLE 64. ABBOTT: KEY EXECUTIVES
TABLE 65. ABBOTT: COMPANY SNAPSHOT
TABLE 66. ABBOTT: OPERATING SEGMENTS
TABLE 67. ABBOTT: PRODUCT PORTFOLIO
TABLE 68. ABBOTT: R&D EXPENDITURE, 2016–2018 ($MILLION)
TABLE 69. ABBOTT: NET SALES, 2016–2018 ($MILLION)
TABLE 70. ARLA: KEY EXECUTIVES
TABLE 71. ARLA: COMPANY SNAPSHOT
TABLE 72. ARLA: OPERATING SEGMENTS
TABLE 73. ARLA: PRODUCT PORTFOLIO
TABLE 74. ARLA: R&D EXPENDITURE, 2016–2018 ($MILLION)
TABLE 75. ARLA: NET SALES, 2016–2018 ($MILLION)
TABLE 76. CAMPBELL SOUP COMPANY: KEY EXECUTIVES
TABLE 77. CAMPBELL SOUP COMPANY: COMPANY SNAPSHOT
TABLE 78. CAMPBELL SOUP COMPANY: OPERATING SEGMENTS
TABLE 79. CAMPBELL SOUP COMPANY: PRODUCT PORTFOLIO
TABLE 80. CAMPBELL SOUP COMPANY: R&D EXPENDITURE, 2016–2018 ($MILLION)
TABLE 81. CAMPBELL SOUP COMPANY: NET SALES, 2016–2018 ($MILLION)
TABLE 82. DANA DAIRY GROUP LTD.: KEY EXECUTIVES
TABLE 83. DANA DAIRY GROUP LTD.: COMPANY SNAPSHOT
TABLE 84. DANA DAIRY GROUP LTD.: PRODUCT PORTFOLIO
TABLE 85. DANONE: KEY EXECUTIVES
TABLE 86. DANONE: COMPANY SNAPSHOT
TABLE 87. DANONE: OPERATING SEGMENTS
TABLE 88. DANONE: PRODUCT PORTFOLIO
TABLE 89. DANONE: R&D EXPENDITURE, 2016–2018 ($MILLION)
TABLE 90. DANONE: NET SALES, 2016–2018 ($MILLION)
TABLE 91. GCMMF: KEY EXECUTIVES
TABLE 92. GCMMF: COMPANY SNAPSHOT
TABLE 93. GCMMF: PRODUCT PORTFOLIO
TABLE 94. GCMMF: NET SALES, 2016–2018 ($MILLION)
TABLE 95. NESTLE S.A: KEY EXECUTIVES
TABLE 96. NESTLE S.A: COMPANY SNAPSHOT
TABLE 97. NESTLE S.A: OPERATING SEGMENTS
TABLE 98. NESTLE S.A: PRODUCT PORTFOLIO
TABLE 99. NESTLE S.A: R&D EXPENDITURE, 2016–2018 ($MILLION)
TABLE 100. NESTLE S.A: NET SALES, 2016–2018 ($MILLION)
TABLE 101. PERRIGO COMPANY PLC: KEY EXECUTIVES
TABLE 102. PERRIGO COMPANY PLC: COMPANY SNAPSHOT
TABLE 103. PERRIGO COMPANY PLC: OPERATING SEGMENTS
TABLE 104. PERRIGO COMPANY PLC: PRODUCT PORTFOLIO
TABLE 105. PERRIGO COMPANY PLC: R&D EXPENDITURE, 2016–2018 ($MILLION)
TABLE 106. PERRIGO COMPANY PLC,: NET SALES, 2016–2018 ($MILLION)
TABLE 107. RECKITT BENCKISER GROUP PLC.: KEY EXECUTIVES
TABLE 108. RECKITT BENCKISER GROUP PLC.: COMPANY SNAPSHOT
TABLE 109. RECKITT BENCKISER GROUP PLC.: OPERATING SEGMENTS
TABLE 110. RECKITT BENCKISER GROUP PLC.: PRODUCT PORTFOLIO
TABLE 111. RECKITT BENCKISER GROUP PLC.: R&D EXPENDITURE, 2016–2018 ($MILLION)
TABLE 112. RECKITT BENCKISER GROUP PLC.: NET SALES, 2016–2018 ($MILLION)
TABLE 113. THE KRAFT HEINZ COMPANY: KEY EXECUTIVES
TABLE 114. THE KRAFT HEINZ COMPANY: COMPANY SNAPSHOT
TABLE 115. THE KRAFT HEINZ COMPANY: PRODUCT PORTFOLIO
TABLE 116. THE KRAFT HEINZ COMPANY: R&D EXPENDITURE, 2016–2018 ($MILLION)
TABLE 117. THE KRAFT HEINZ COMPANY: NET SALES, 2016–2018 ($MILLION)
LIST OF FIGURES
FIGURE 01. KEY MARKET SEGMENTS
FIGURE 02. EXECUTIVE SUMMARY
FIGURE 03. TOP IMPACTING FACTORS
FIGURE 04. TOP INVESTMENT POCKETS
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. HIGH BARGAINING POWER OF BUYERS
FIGURE 07. MODERATE THREAT OF SUBSTITUTION
FIGURE 08. HIGH THREAT OF NEW ENTRANTS
FIGURE 09. HIGH INTENSITY OF COMPETITIVE RIVALRY
FIGURE 10. TOP PLAYER POSITIONING
FIGURE 11. DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 12. ASIA-PACIFIC BABY INFANT FORMULA MARKET, BY TYPE, 2017–2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR INFANT MILK, BY COUNTRY, 2017 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR FOLLOW-ON MILK, BY COUNTRY, 2017 & 2026 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR SPECIALTY BABY MILK, BY COUNTRY, 2017 & 2026 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR GROWING-UP MILK, BY COUNTRY, 2017–2026 (%)
FIGURE 17. ASIA-PACIFIC BABY INFANT FORMULA MARKET, BY INGREDIENT, 2017–2026 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR CARBOHYDRTAE, BY COUNTRY, 2017 & 2026 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR FAT, BY COUNTRY, 2017 & 2026 (%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR PROTEIN, BY COUNTRY, 2017 & 2026 (%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR MINERALS, BY COUNTRY, 2017 & 2026 (%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR VITAMINS, BY COUNTRY, 2017 & 2026 (%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR OTHERS, BY COUNTRY, 2017 & 2026 (%)
FIGURE 24. ASIA-PACIFIC BABY INFANT FORMULA MARKET, BY DISTRIBUTION CHANNEL, 2017–2026(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR HYPERMARKET, BY COUNTRY, 2017-2026(%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR SUPERMARKET, BY COUNTRY, 2017-2026(%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR PHARMACY/MEDICAL STORE, BY COUNTRY, 2017-2026(%)
FIGURE 28. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR SPECIALTY STORES, BY COUNTRY, 2017-2026(%)
FIGURE 29. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR HARD DISCOUNTER STORE, BY COUNTRY, 2017-2026(%)
FIGURE 30. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR E-COMMERCE, BY COUNTRY, 2017-2026(%)
FIGURE 31. COMPARATIVE SHARE ANALYSIS OF ASIA-PACIFIC BABY INFANT FORMULA MARKET FOR OTHERS, BY COUNTRY, 2017-2026(%)
FIGURE 32. ASIA-PACIFIC BABY INFANT MARKET, BY COUNTRY, 2017–2026 (%)
FIGURE 33. CHINA BABY INFANT FORMULA MARKET REVENUE, 2017–2026 ($MILLION)
FIGURE 34. INDIA BABY INFANT FORMULA MARKET REVENUE, 2017–2026 ($MILLION)
FIGURE 35. SOUTH KOREA BABY INFANT FORMULA MARKET REVENUE, 2017–2026 ($MILLION)
FIGURE 36. JAPAN BABY INFANT FORMULA MARKET REVENUE, 2017–2026 ($MILLION)
FIGURE 37. PHILIPPINES BABY INFANT FORMULA MARKET REVENUE, 2017–2026 ($MILLION)
FIGURE 38. INDONESIA BABY INFANT FORMULA MARKET REVENUE, 2017–2026 ($MILLION)
FIGURE 39. AUSTRALIA BABY INFANT FORMULA MARKET REVENUE, 2017–2026 ($MILLION)
FIGURE 40. NEW ZEALAND BABY INFANT FORMULA MARKET REVENUE, 2017–2026 ($MILLION)
FIGURE 41. REST OF ASIA-PACIFIC BABY INFANT FORMULA MARKET REVENUE, 2017–2026 ($MILLION)
FIGURE 42. PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 43. COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 44. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 45. ABBOTT: R&D EXPENDITURE, 2016–2018 ($MILLION)
FIGURE 46. ABBOTT: NET SALES, 2016–2018 ($MILLION)
FIGURE 47. ABBOTT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48. ABBOTT: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 49. ARLA: R&D EXPENDITURE, 2016–2018 ($MILLION)
FIGURE 50. ARLA: NET SALES, 2016–2018 ($MILLION)
FIGURE 51. ARLA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 52. ARLA: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 53. CAMPBELL SOUP COMPANY: R&D EXPENDITURE, 2016–2018 ($MILLION)
FIGURE 54. CAMPBELL SOUP COMPANY: NET SALES, 2016–2018 ($MILLION)
FIGURE 55. CAMPBELL SOUP COMPANY: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 56. CAMPBELL SOUP COMPANY: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 57. DANONE: R&D EXPENDITURE, 2016–2018 ($MILLION)
FIGURE 58. DANONE: NET SALES, 2016–2018 ($MILLION)
FIGURE 59. DANONE: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 60. DANONE: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 61. GCMMF: NET SALES, 2016–2018 ($MILLION)
FIGURE 62. NESTLE S.A: R&D EXPENDITURE, 2016–2018 ($MILLION)
FIGURE 63. NESTLE S.A: NET SALES, 2016–2018 ($MILLION)
FIGURE 64. NESTLE S.A: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 65. NESTLE S.A: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 66. PERRIGO COMPANY PLC: R&D EXPENDITURE, 2016–2018 ($MILLION)
FIGURE 67. PERRIGO COMPANY PLC,: NET SALES, 2016–2018 ($MILLION)
FIGURE 68. PERRIGO COMPANY PLC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 69. PERRIGO COMPANY PLC.: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 70. RECKITT BENCKISER GROUP PLC.: R&D EXPENDITURE, 2016–2018 ($MILLION)
FIGURE 71. RECKITT BENCKISER GROUP PLC.: NET SALES, 2016–2018 ($MILLION)
FIGURE 72. RECKITT BENCKISER GROUP PLC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 73. RECKITT BENCKISER GROUP PLC.: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 74. THE KRAFT HEINZ COMPANY: R&D EXPENDITURE, 2016–2018 ($MILLION)
FIGURE 75. THE KRAFT HEINZ COMPANY: NET SALES, 2016–2018 ($MILLION)
FIGURE 76. THE KRAFT HEINZ COMPANY: REVENUE SHARE BY PRODUCT CATEGORY, 2018 (%)
FIGURE 77. THE KRAFT HEINZ COMPANY: REVENUE SHARE BY REGION, 2018 (%)
$5899
$9213
